Market Overview:
The global Chinese medicine injection market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of chronic diseases, rising demand for minimally invasive treatments, and growing awareness about traditional Chinese medicines (TCMs). The global Chinese medicine injection market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into detoxification drugs, cardiovascular disease medications, cerebrovascular disease medications, anti-tumor drugs and other types. The detoxification drug segment is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. This growth can be attributed to increasing awareness about detoxification therapies among consumers and healthcare professionals. On the basis of application, adult patients accounted for majority share in 2017 and this trend is projected to continue during the forecast period from 2018 To 2030 owing higher incidence rates for chronic diseases such as cancer and heart disorders across all regions globally. However; children are also increasingly being prescribed with Chinese medicine injections owing their vulnerability towards developing chronic diseases at an early age in future which would fuel demand for these products over next few years .Regionally North America held largest share in 2017 followed by Europe due its well-developed healthcare infrastructure coupled with high adoption rateof innovative technologies across various medical segments including traditional chinese medicines Injection therapy .
Product Definition:
A Chinese medicine injection is a type of injection that uses traditional Chinese medicine to treat various conditions. It is often used to treat chronic pain, inflammation, and other conditions.
Detoxification:
Detoxification is the process of eliminating toxins from the body. It's a natural healing process that helps in improving body functions and removing harmful substances from the human body.
Detoxification is an important concept in Chinese medicine as it helps harmonize yin & yang, balance blood sugar levels, improve digestion and eliminate waste products such as uric acid crystals & other acids formed during kidney disease or gouty arthritis.
Cardiovascular Disease Medication:
Cardiovascular disease (CVD) medication and it's usage in Chinese medicine injection market is expected to grow at a lucrative rate during the forecast period. The major factor that propels this growth includes prevalence of CVDs, increasing geriatric population base, growing awareness about alternative therapies and lack of proper diagnosis facilities for cardiovascular diseases in China.
Application Insights:
Based on application, the market is segmented into adult and children. The adult segment held the largest share in 2017 due to a large patient base and rising prevalence of chronic diseases such as cancer, cardiovascular disease, diabetes mellitus CVDs & diabetes), respiratory disorders (SARS-CoV-2) and infectious diseases. Moreover, increasing geriatric population across China coupled with high incidence rate of cancer is expected to drive demand for Chinese herbal medicine injections in near future.
The growing importance of maintaining brain health along with growing incidences of Alzheimer¢â‚¬â„¢s disease as well as mild cognitive impairment (MCI) has led researchers from Peking University Health System to explore novel therapeutic options for treating these conditions through traditional Chinese medicine. In addition, increasing R&D initiatives by major players such as Zhejiang University School Of Medicine are expected to boost market growth over the forecast period.
Regional Analysis:
In terms of region, Asia Pacific dominated the global Chinese medicine injection market in 2017. The presence of a large number of local players and suppliers coupled with growing demand for traditional Chinese medicine is expected to drive the regional market over the forecast period. In addition, increasing cases of chronic diseases due to unhealthy lifestyles are anticipated to further boost product demand in this region.
The Asia Pacific Traditional Medicine Association (APTM) was established by governments from China and Taiwan with an aim to promote traditional medicines across this region. APTM has its offices in Beijing, Shanghai, Guangzhou and Hong Kong where they conduct research on traditional medicines as well as organize conferences for promoting awareness about these products among consumers and healthcare professionals alike.
Growth Factors:
- Increasing demand for minimally invasive treatments: The growing preference for minimally invasive procedures is driving the demand for Chinese Medicine Injection market.
- Technological advancements: The introduction of technologically advanced products is propelling the growth of this market.
- Rising geriatric population: The increasing number of elderly people is leading to an increase in the demand for Chinese Medicine Injection products, as these products are used to treat various age-related disorders and conditions.
- Growing awareness about traditional Chinese medicine: There is a growing awareness about traditional Chinese medicine among consumers, which is aiding the growth of this market segment. 5) Rising healthcare expenditure: The rising healthcare expenditure worldwide is boosting the demand for various medical devices and therapies, including those offered by the Chinese Medicine Injection market
Scope Of The Report
Report Attributes
Report Details
Report Title
Chinese Medicine Injection Market Research Report
By Type
Detoxification, Cardiovascular Disease Medication, Cerebrovascular Disease Medication, Anti-tumor Drugs, other
By Application
Adult, Children
By Companies
Green Valley Pharma, Changbaishan Pharmaceutical, Zhejiang Kanglaite Pharmaceutical, Qingfeng Pharmaceutical Group, Buchang Pharmaceutical, Livzon, ZBD Pharmaceutical, Chase Sun Pharmaceutical, Wuzhou Pharmaceutical, Yusheng Pharmaceutical, Harbin Pharmaceutical Group, Fusen Pharmaceutical, Gerun Pharmaceutical, Shineway Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
120
Number of Tables & Figures
84
Customization Available
Yes, the report can be customized as per your need.
Global Chinese Medicine Injection Market Report Segments:
The global Chinese Medicine Injection market is segmented on the basis of:
Types
Detoxification, Cardiovascular Disease Medication, Cerebrovascular Disease Medication, Anti-tumor Drugs, other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adult, Children
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Green Valley Pharma
- Changbaishan Pharmaceutical
- Zhejiang Kanglaite Pharmaceutical
- Qingfeng Pharmaceutical Group
- Buchang Pharmaceutical
- Livzon
- ZBD Pharmaceutical
- Chase Sun Pharmaceutical
- Wuzhou Pharmaceutical
- Yusheng Pharmaceutical
- Harbin Pharmaceutical Group
- Fusen Pharmaceutical
- Gerun Pharmaceutical
- Shineway Pharmaceutical
Highlights of The Chinese Medicine Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Detoxification
- Cardiovascular Disease Medication
- Cerebrovascular Disease Medication
- Anti-tumor Drugs
- other
- By Application:
- Adult
- Children
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chinese Medicine Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chinese Medicine Injection is a type of injection that uses acupuncture and herbs to treat conditions such as pain, inflammation, and stress.
Some of the major players in the chinese medicine injection market are Green Valley Pharma, Changbaishan Pharmaceutical, Zhejiang Kanglaite Pharmaceutical, Qingfeng Pharmaceutical Group, Buchang Pharmaceutical, Livzon, ZBD Pharmaceutical, Chase Sun Pharmaceutical, Wuzhou Pharmaceutical, Yusheng Pharmaceutical, Harbin Pharmaceutical Group, Fusen Pharmaceutical, Gerun Pharmaceutical, Shineway Pharmaceutical.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chinese Medicine Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Chinese Medicine Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Chinese Medicine Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Chinese Medicine Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Chinese Medicine Injection Market Size & Forecast, 2018-2028
4.5.1 Chinese Medicine Injection Market Size and Y-o-Y Growth
4.5.2 Chinese Medicine Injection Market Absolute $ Opportunity
Chapter 5 Global Chinese Medicine Injection Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Chinese Medicine Injection Market Size Forecast by Type
5.2.1 Detoxification
5.2.2 Cardiovascular Disease Medication
5.2.3 Cerebrovascular Disease Medication
5.2.4 Anti-tumor Drugs
5.2.5 other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Chinese Medicine Injection Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Chinese Medicine Injection Market Size Forecast by Applications
6.2.1 Adult
6.2.2 Children
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chinese Medicine Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chinese Medicine Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Chinese Medicine Injection Analysis and Forecast
9.1 Introduction
9.2 North America Chinese Medicine Injection Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Chinese Medicine Injection Market Size Forecast by Type
9.6.1 Detoxification
9.6.2 Cardiovascular Disease Medication
9.6.3 Cerebrovascular Disease Medication
9.6.4 Anti-tumor Drugs
9.6.5 other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Chinese Medicine Injection Market Size Forecast by Applications
9.10.1 Adult
9.10.2 Children
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Chinese Medicine Injection Analysis and Forecast
10.1 Introduction
10.2 Europe Chinese Medicine Injection Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Chinese Medicine Injection Market Size Forecast by Type
10.6.1 Detoxification
10.6.2 Cardiovascular Disease Medication
10.6.3 Cerebrovascular Disease Medication
10.6.4 Anti-tumor Drugs
10.6.5 other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Chinese Medicine Injection Market Size Forecast by Applications
10.10.1 Adult
10.10.2 Children
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Chinese Medicine Injection Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Chinese Medicine Injection Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Chinese Medicine Injection Market Size Forecast by Type
11.6.1 Detoxification
11.6.2 Cardiovascular Disease Medication
11.6.3 Cerebrovascular Disease Medication
11.6.4 Anti-tumor Drugs
11.6.5 other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Chinese Medicine Injection Market Size Forecast by Applications
11.10.1 Adult
11.10.2 Children
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Chinese Medicine Injection Analysis and Forecast
12.1 Introduction
12.2 Latin America Chinese Medicine Injection Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Chinese Medicine Injection Market Size Forecast by Type
12.6.1 Detoxification
12.6.2 Cardiovascular Disease Medication
12.6.3 Cerebrovascular Disease Medication
12.6.4 Anti-tumor Drugs
12.6.5 other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Chinese Medicine Injection Market Size Forecast by Applications
12.10.1 Adult
12.10.2 Children
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Chinese Medicine Injection Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Chinese Medicine Injection Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Chinese Medicine Injection Market Size Forecast by Type
13.6.1 Detoxification
13.6.2 Cardiovascular Disease Medication
13.6.3 Cerebrovascular Disease Medication
13.6.4 Anti-tumor Drugs
13.6.5 other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Chinese Medicine Injection Market Size Forecast by Applications
13.10.1 Adult
13.10.2 Children
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chinese Medicine Injection Market: Competitive Dashboard
14.2 Global Chinese Medicine Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Green Valley Pharma
14.3.2 Changbaishan Pharmaceutical
14.3.3 Zhejiang Kanglaite Pharmaceutical
14.3.4 Qingfeng Pharmaceutical Group
14.3.5 Buchang Pharmaceutical
14.3.6 Livzon
14.3.7 ZBD Pharmaceutical
14.3.8 Chase Sun Pharmaceutical
14.3.9 Wuzhou Pharmaceutical
14.3.10 Yusheng Pharmaceutical
14.3.11 Harbin Pharmaceutical Group
14.3.12 Fusen Pharmaceutical
14.3.13 Gerun Pharmaceutical
14.3.14 Shineway Pharmaceutical
